α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

Asahina, Yasuhiro; Tsuchiya, Kaoru; Nishimura, Takashi; Muraoka, Masaru; Suzuki, Yuichiro; Tamaki, Nobuharu; Yasui, Yutaka; Hosokawa, Takanori; Ueda, Ken; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Kurosaki, Masayuki; Enomoto, Nobuyuki; Nakagawa, Mina; Kakinuma, Sei; Watanabe, Mamoru; Izumi, Namiki

doi:10.1002/hep.26442

Public

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

Published in Hepatology • Apr 8, 2013

Authors:

Yasuhiro Asahina

Kaoru Tsuchiya

Takashi Nishimura

Abstract

UNLABELLED: The effects of interferon (IFN) treatment and the post-IFN treatment α-fetoprotein (AFP) levels on risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC) are unknown. To determine the relationship between AFP and alanine transaminase (ALT) levels and HCC risk, ...

Subject

Hepatocellular carcinoma

Medicine

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!